Skip to content
OpenCapital
Get started

Disc Medicine IRON Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$1.03M-55.2%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$1.14M-15.1%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$4.11M+77.9%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0×0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's accretion (amortization) of discounts and premiums, investments?
Disc Medicine (IRON) reported accretion (amortization) of discounts and premiums, investments of $1.07M in Q1 2026.
How has Disc Medicine's accretion (amortization) of discounts and premiums, investments changed year-over-year?
Disc Medicine's accretion (amortization) of discounts and premiums, investments decreased by 57.7% year-over-year, from $2.53M to $1.07M.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to net income for the amortization of premiums or accretion of discounts on debt securities held as investments. It reflects the gradual adjustment of the carrying value of investment securities toward their face value over time. This metric is essential for reconciling net income with actual cash flows generated from investment portfolios.